Kenneth Rivlin, MD, PhD

Department: Hematology/Oncology

718-918-5170

Bio

Dr. Rivlin is the Director of the Division of Pediatric Hematology and Oncology. He has a strong interest in Sickle Cell Disease is a member of the New York Sickle Cell Advisory Committee. He has served as Principle Investigator on HRSA Sickle Cell Grants and was a member of the NIH Planning Committee for the Consensus Statement on Use of Hydroxyurea. Dr. Rivlin is the Principle Investigator of two studies, Randomized Double Blind Trial of Rivipansel in the Treatment of Vasoocclusive Crises in Hospitalized Patients with Sickle Cell Disease and An Open-Label Extension Study to Evaluate The Safety of Rivipansel in the Treatment of One or More Vasoocclusive Crises in Hospitalized Patients with Sickle Cell Disease.

Dr. Rivlin has worked in the Caribbean and Guyana on improving comprehensive sickle cell care. Dr. Rivlin is board certified in Pediatric Hematology-Oncology and he is an Assistant Professor of Pediatrics at the Albert Einstein College of Medicine.

Education & Training

Undergraduate School:
H. H. Lehman College

Graduate School:
Fordham University

Medical School:
Technion, Israel Institute of Technology

Training:

  • Internship and Residency: Mayo Clinic Graduate School of Medicine
  • Pediatric Hematology-Oncology Fellowship: Memorial Sloan-Kettering Cancer Center
  • Pediatric Hematology-Oncology Chief Fellowship: Memorial Sloan-Kettering Cancer Center

Honors & Awards

  • Henry Barnett Teaching Award, Department of Pediatrics, Jacobi Medical Center, 2009
  • Mentor, Academic Pediatrics Association Research Award for Best Abstract by a Resident, 2011
  • Selected as “Favorite Teacher” by the Albert Einstein College of Medicine, Class of 2012      
  • Community Leadership Award, Candice Sickle Cell Fund, Inc., 2018

Bibliography

Articles

  • Kim T, Yershalmi R, Margulis, K, Badner V, Rivlin K: Diagnosis of hypofibrinogenemia after dental treatment under general anesthesia. Pediatric Dentistry. 2018 40(1):217-19.
  • Gershel J, Kreiner R, Spitzer G, Slotkin EK, Sterman A, Rivlin K: Usefulness of the C-reactive protein in predicting the need for antibiotics among febrile inpatients with sickle cell disease. Open Infect Dis J 2015:9:26-9.
  • Sia VM, Sia DC, Yamashiro DJ, Rivlin K, et al. A common symptom of an uncommon disease. J Pediatr Hematol Oncol. 2011 33(5):390-1.

Chapters in Books

  • Rivlin K. Sickle Cell Disease. In Rauch DR, Gershel JC (eds.): Caring for the Hospitalized Child: A Handbook of Inpatient Pediatrics. 267-75.
  • Rivlin K, Romo N. Sickle Cell Disease. In Gershel JC, Rauch DA, eds: Caring for the Hospitalized Child: A Handbook of Inpatient Pediatrics (2nd ed). Elk Grove, IL: American Academy of Pediatrics; 2017, pp 319-29.

Abstracts (Recent)

  • Okito O, Lad Y, Rodriquez D, Gershel J, Rivlin K. Identifying the Hidden Curriculum in Teaching Patient Family Centered Care. Presented at the Pediatric Academic Societies Meeting, Baltimore, MD, May 2, 2016.
  • Rodriquez D, Gershel J, Burks A, Rivlin K. Using Implementation Research to Assess the Barriers to Reproducing a Successful Model for Resident QI Projects. Presented at the Pediatric Academic Societies Meeting, Baltimore, MD, May 1, 2016.
  • Aziz K, Romo ND, Rivlin K, Gershel JC. Pediatric Readmissions at an Inner City Safety-Net Hospital. Presented at the Eastern Society for Pediatric Research Meeting, Philadelphia, PA, March 11, 2016
  • McCann T, Miller S, Gershel JC, Rivlin K: Resident Implementation of an Always Event (AE): A Tool for Experiential Learning of Patient Family Centered Care (PFCC). ). Presented at the Pediatric Academic Societies Meeting, Washington, DC, May 7, 2013.
  • Beiner J, Toberman S, Rivlin K, Gershel JC: A Ten-Year Perspective of Admission Diagnoses at a General Teaching Hospital: Implications for Resident Education. Presented at the Pediatric Academic Societies Meeting, Washington, DC, May 7, 2013.
  • Chen S, Taylor T, Gershel JC, Rivlin K: The NCAA Policy for Sickle Cell Trait (SCT) Screening: A Flawed Policy in Need of a Health Impact Assessment (HIA). Presented at the Pediatric Academic Societies Meeting, Washington, DC, May 7, 2013.
  • McCann T, Edelman E, Oliver D, Gershel JC, Rivlin K: Learning Patient Family Centered Care: The Patient/Family Advisor as a Resource for Immediate Resident Feedback. Presented at the Pediatric Academic Societies Meeting, Washington, DC, May 4, 2013.
  • Romo ND, Sukumuran L, Kim JL, Rivlin K, Gershel JC: The changing epidemiology of sepsis among infants
  • Gershel JC, Epstein R, Sterman A, Slotkin E, Spitzer G, Rivlin K: Can The C-reactive protein predict which inpatients with sickle cell disease require antibiotics? Presented at the Pediatric Hospital Medicine 2012 Meeting, Cincinnati, July 19, 2012.
  • Edelman M, Romo N, Romm J, Gershel J, Rivlin K: Pediatric resident gripes, normalization of deviance, and housestaff culture. Presented at the Pediatric Academic Societies Meeting, Boston, April 30, 2012.
  • Romo ND, Sukumuran L, Kim JL, Rivlin K, Gershel J: Association of prior antibiotics exposure and increased risk of serious bacterial infection in infants. Presented at the Pediatric Academic Societies Meeting, Boston, April 29, 2012.

Grants (Recent)

  • Principle Investigator, Integrating System Medicine into PBL. Albert Einstein College of Medicine GME Grant, 2011-2013.
  • Principal Investigator, Turning Patient Gripes into Resident QI Projects. Picker/Gold GME Challenge Grant, 2011-2012.
  • NYS Principle Investigator, Regional Sickle Cell Treatment Demonstration Grant, Heath Resources and Services Administration, 2014-2017.
  • Principle Investigator, Patient Centered Medical Record, Picker/Gold GME Challenge Grant 2015-2017.
  • Resident Bright Futures Literacy Project, Committee for Interns and Residents, 2015.
  • NYS Principle Investigator, NE Regional Sickle Cell Treatment Demonstration Grant, Heath Resources and Services Administration, 2017-2021.